Gapping up
In reaction to strong earnings/guidance:
- HEAR +27.8% (guidance), LEN +0.5%
Other news:
- IDYA +117.9% (partners with GSK covering three IDEAYA Synthetic Lethality programs) IQ +34.8% (Tencent (TCEHY) wants to become largest shareholder of IQ, according to Reuters)
- WW +13.7% (provides update; Subs as of June 6 totaled 4.9 mln, up 7% yr/yr)
- NYMT +13.3% (resumes dividend)
- ERI +10% (stock offering; also to enter into a $400 mln mortgage)
- LLY +8.5% (receives FDA approval for Lyumjev; reports Verzenio in combination with standard adjuvant endocrine therapy met the primary endpoint)
- SWBI +6.8% (extends momentum)
- PLYA +6.5% (S&P downgrade)
- NKLA +6% (stock offering)
- IDEX +5.5% (to sell its Grapevine and related influencer platform)
- LMPX +5.5% (names new CFO)
- CLDX +5% (prices offering 13,377,926 shares of its common stock at a price to the public of $9.75 per share)
- FHN +5% (receive regulatory approval for proposed merger)
- DSSI +4.8% (announces strategic product tanker partnership with NORDEN)
- STOR +4.2% (details comments made during call - through June 15, 2020, it had received cash payments representing approximately 76% of scheduled June rent and interest on its active contracts)
- FTI +4.2% (entered into Amendment No 1. to its $2.5 billion senior unsecured revolving credit facility agreement and an Amendment and Restatement Agreement to its €500 million senior unsecured revolving credit facility agreement)
- CZR +3.9% (reports preliminary operating trends for Caesars' Properties that reopened in May and June 2020)
- TIF +1.6% (Tiffany & Co / LVMH (LVMUY) merger was cleared on June 12 by the Korea Fair Trade Commission of South Korea)
- KN +1.5% (announces workforce reduction)
- SNY +1.3% (invests to make France its center in vaccine research and production)
- UNVR +1.2% (reaches new distribution agreement with Biosynthetic Tech)
- ZM +1.1% (announces that the Zoom Phone added to Zoom for Govt)
Analyst comments:
- SUPN +7.7% (upgraded to Overweight from Neutral at Piper Sandler)
- QRVO +4.3% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- LRCX +3.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- CSCO +3.7% (upgraded to Buy from Neutral at BofA/Merrill)
- LX +3.7% (upgraded to Buy from Hold at China Renaissance)
- QCOM +3.3% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- ALC +2.2% (upgraded to Buy from Neutral at Guggenheim)
- AAPL +1.8% (target raised to $400 from $310 at Citigroup; raised to $425 at Wedbush)
- GATX +1.4% (upgraded to Overweight from Equal-Weight at Stephens)